BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 15217500)

  • 1. Chemically induced DNA hypomethylation in breast carcinoma cells detected by the amplification of intermethylated sites.
    Sadikovic B; Haines TR; Butcher DT; Rodenhiser DI
    Breast Cancer Res; 2004; 6(4):R329-37. PubMed ID: 15217500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzopyrene exposure disrupts DNA methylation and growth dynamics in breast cancer cells.
    Sadikovic B; Rodenhiser DI
    Toxicol Appl Pharmacol; 2006 Nov; 216(3):458-68. PubMed ID: 16926039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation analysis using CpG microarrays is impaired in benzopyrene exposed cells.
    Sadikovic B; Andrews J; Rodenhiser DI
    Toxicol Appl Pharmacol; 2007 Dec; 225(3):300-9. PubMed ID: 17904174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation and inhibition of expression of uPA by the RAS oncogene: divergence of growth control and invasion in breast cancer cells.
    Pakneshan P; Szyf M; Rabbani SA
    Carcinogenesis; 2005 Mar; 26(3):557-64. PubMed ID: 15618232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers.
    Rodriguez J; Frigola J; Vendrell E; Risques RA; Fraga MF; Morales C; Moreno V; Esteller M; Capellà G; Ribas M; Peinado MA
    Cancer Res; 2006 Sep; 66(17):8462-9468. PubMed ID: 16951157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation of estrogen receptor beta promoter correlates with loss of ER-beta expression in mammary carcinoma and is an early indication marker in premalignant lesions.
    Rody A; Holtrich U; Solbach C; Kourtis K; von Minckwitz G; Engels K; Kissler S; Gätje R; Karn T; Kaufmann M
    Endocr Relat Cancer; 2005 Dec; 12(4):903-16. PubMed ID: 16322330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
    Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of DNA methylation by amplification of intermethylated sites (AIMS).
    Jordà M; Rodríguez J; Frigola J; Peinado MA
    Methods Mol Biol; 2009; 507():107-16. PubMed ID: 18987810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation and cancer.
    Jones PA
    Cancer Res; 1986 Feb; 46(2):461-6. PubMed ID: 2416425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypomethylation of cytosine 5-methyltransferase in human neoplasms.
    Butler TL; Kay PH; Jacobsen PF
    Anticancer Res; 2000; 20(3A):1435-8. PubMed ID: 10928053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
    Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.
    Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M
    Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long term instability and molecular mechanism of 5-azacytidine-induced DNA hypomethylation in normal and neoplastic tissues in vivo.
    Lu LJ; Randerath K
    Mol Pharmacol; 1984 Nov; 26(3):594-603. PubMed ID: 6208475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein.
    Park IY; Sohn BH; Yu E; Suh DJ; Chung YH; Lee JH; Surzycki SJ; Lee YI
    Gastroenterology; 2007 Apr; 132(4):1476-94. PubMed ID: 17408664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant CBFA2T3B gene promoter methylation in breast tumors.
    Bais AJ; Gardner AE; McKenzie OL; Callen DF; Sutherland GR; Kremmidiotis G
    Mol Cancer; 2004 Aug; 3():22. PubMed ID: 15301688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a genomic fragment that directs hematopoietic-specific expression of Rac2 and analysis of the DNA methylation profile of the gene locus.
    Ladd PD; Butler JS; Skalnik DG
    Gene; 2004 Oct; 341():323-33. PubMed ID: 15474314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection and significance of APC gene promoter hypermethylation in serum of breast cancer patients].
    Zhang JJ; Ouyang T; Wan WH; Xu GW; Deng GR
    Ai Zheng; 2007 Jan; 26(1):44-7. PubMed ID: 17222366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.
    Shutoh M; Oue N; Aung PP; Noguchi T; Kuraoka K; Nakayama H; Kawahara K; Yasui W
    Cancer; 2005 Oct; 104(8):1609-19. PubMed ID: 16134180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
    Jiang Y; Tong D; Lou G; Zhang Y; Geng J
    Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.